We report the case of a man who developed myelodysplastic syndrome (MDS) and refractory cytopenia of unilineage dysplasia, 5 months after aortic valve replacement surgery. He also developed fever of unknown origin. After bone marrow-and other laboratory examinations, he was diagnosed with tuberculosis.
Case Report
A 58-year-old man underwent aortic valve replacement surgery in March 2018. Five months after the operation, he developed anemia and blasts appeared in a peripheral blood test (white blood cell count 7800/µL, hemoglobin 8.4 g/dL, platelet count 15.4×10 4 /µL, blasts 1.5%). He underwent bone marrow examination (BME) (nucleated cell count [NCC] 5.0×10 4 /µL, blasts 3.7%, ringed sideroblasts 53.0%), and was diagnosed with myelodysplastic syndrome (MDS) and refractory cytopenia of unilineage dysplasia (RCUD) without any cytogenetic abnormality. After the examination, he arrived at the hospital with high-grade fever (38.5°C) and no other symptoms. Laboratory examination revealed anemia without progression. To rule out progression of MDS, he underwent BME again; however, the blast count was 4.0% (NCC 5.0×10 4 /µL), unchanged from the previous BME.
To rule out infection focus we performed a computed tomography (CT) scan, which showed extensive lymphadenopathy in the paratracheal region without pulmonary infiltration ( Figure 1 ). We suspected infection of the upper respiratory tract; however, all cultures were negative. Despite starting the patient on empiric antibiotics, the fever persisted for a week. He then underwent mediastinal lymph node biopsy by thoracoscope. Histopathologic examination showed granulamatous lymphadenitis with necrosis including multinucleated giant cells, mostly suggesting tuberculosis (TB) ( Figure 2 ). Upon Ehrlich-Ziehl-Neelsen staining, both Mycobacterium tuberculosis and interferongamma release assay (QuantiFeron®) were positive. After a course of isoniazid, rifampicin, and ethambutol, the patient's fever resolved and the lymphadenopathy disappeared.
Discussion and Conclusions
MDS is a group of clonal myeloid disorders that often progress to acute leukemia. Pancytopenia is a common finding. Cell-mediated immunity is seriously impaired and patients are predisposed to infections, which account for 4 The major host defense against TB is cell-mediated immunity. It has been reported that there are serious defects in the lymphoid system in addition to abnormalities in the myeloid populations of MDS patients, such as decreased absolute numbers of T lymphocytes and markedly decreased CD4+/CD8+ ratio. 5 Because our patient underwent aortic valve replacement surgery before he developed fever, we at first suspected infection affecting the operation site. CT showed lymphadenopathy without lung lesions, which led us to suspect infection around the respiratory tract. Previous studies reported that the right paratracheal region was the most frequently involved nodal site in immunocompetent and immunocompromised patients with TB. 6 Kim et al. investigated 195 MDS patients and revealed 12 TB patients in this cohort, 50% of whom had extrapulmonary involvement. 4 Thus, the initial symptom of TB appears to be extrapulmonary, which may be common in an immunocompromised host.
Our patient presented with a fever of unknown origin (FUO). Generally, TB is considered to be one of the most common infections to produce FUO, although it never occurred to us because of the patient's disparate clinical history. For this reason, we must encourage awareness that TB may be a common infection in MDS, and should thus be considered in the differential diagnosis of patients with MDS presenting with any type of lymphadenopathy.
